Published in Blood Weekly, June 15th, 2006
According to a recently published study from the United States, "Alpha4 integrin or VLA4 (CD49d/CD29) is a multitask molecule with wide expression within and outside the hematopoietic system.
"Because targeted ablation of alpha 4 integrin leads to embryonic lethality, to study its effects on adult hematopoiesis, we used animals with conditional excision of alpha 4 integrin (alpha 4(Delta/Delta)) in hematopoietic cells."
"In such animals," wrote G.V. Priestley and colleagues at the University of Washington, "we previously documented...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.